FDA NDC Directory · JSON-LD · Markdown

INPEFA

NDC 70183-221 · HUMAN PRESCRIPTION DRUG · TABLET

Generic namesotagliflozin
Labeler / ManufacturerLexicon Pharmaceuticals, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA216203
Dosage form / routeTABLET · ORAL
Active ingredientsSOTAGLIFLOZIN (200 mg/1)
Marketing started20230526
Package count3

External sources

Source: openFDA. Public-domain (CC0).